Teicoplanin Seacross 200 mg powder for solution for injection / infusion or oral solution

Licence status
Authorised: 10/01/2025
Active substances
Teicoplanin
Dosage Form
Powder for solution for injection/infusion
Licence number
PA22766/011/001
Licence holder
Seacross Pharma (Europe) Limited

Product documents

Licence information

ATC code
J01XA02 teicoplanin
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
10/01/2025